Evidence map›Paper›PMID 34968323›Full record

ArticleNursing reports (Pavia, Italy)2021

Healthcare Provider Attitudes toward the Newly Developed COVID-19 Vaccine: Cross-Sectional Study.

Gasmelseed Ahmed, Zainab Almoosa, Dalia Mohamed, Janepple Rapal, Ofelia Minguez, Issam Abu Khurma, Ayman Alnems, Abbas Al Mutair

Abstract read
In one paragraph

Article in Nursing reports (Pavia, Italy), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gasmelseed AhmedResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Zainab AlmoosaResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Dalia MohamedResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Janepple RapalResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Ofelia MinguezResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Issam Abu KhurmaResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Ayman AlnemsResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.
Abbas Al MutairResearch Center, Almoosa Specialist Hospital, Al-ahsa 36342, Saudi Arabia.ORCID 0000-0002-9471-2767

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDuring the long wait and the global anxiety for a vaccine against COVID-19, impressively high-safety and effective vaccines were invented by multiple pharmaceutical companies.

aimWe aimed to assess the attitudes of healthcare providers and evaluate their intention to advocate for the vaccine.

methodsThis was a cross-sectional study conducted in a tertiary private hospital where an electronic survey was distributed among healthcare providers (HCPs). The survey contained two sections: socio-demographic characteristics and Likert-scale perception, with 72% internal consistency.

resultsThe response rate to the email survey was 37% (n = 236). In addition, 169 (71.6%) of respondents were women, with more than half (134, 56.8%) aged ≤35 years. A total of 110 (46.6%) had over 10 years of experience, and most of them were nurses (146, 62%). Univariate analysis revealed that older participants significantly accepted and advocated for the new vaccine more than the younger ones. In the multivariate analysis, men were significantly more likely than women to accept and advocate for the new vaccine, as were those with chronic illnesses. Participants with allergy were significantly less likely to accept the vaccine than others. odds ratio (OR) and

conclusionThe acceptance rate for the newly-developed COVID-19 vaccines was average among HCPs. Sex, age, presence of chronic illnesses, and allergy were significant predictors of accepting the vaccine.

Indexed as

acceptanceadvocateattitudesCOVID-19healthcare providersSaudi Arabiavaccination

Identifiers

PMID34968323
PMCPMC8608117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.